Developing a Standardized Definition for Disease "Flare" in Rheumatoid Arthritis (OMERACT 9 Special Interest Group)

被引:102
作者
Bingham, Clifton O., III
Pohl, Christoph
Woodworth, Tasia G.
Hewlett, Sarah E.
May, James E.
Rahman, Mahboob U.
Witter, James P.
Furst, Daniel E.
Strand, C. Vibeke
Boers, Maarten
Alten, Rieke E.
机构
[1] Charite, Schlosspk Klin, D-13353 Berlin, Germany
[2] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England
[3] Univ Calif Los Angeles, Los Angeles, CA USA
[4] Univ W England, Bristol BS16 1QY, Avon, England
[5] Univ Penn, Philadelphia, PA 19104 USA
[6] Centocor Inc, Philadelphia, PA USA
[7] NIAMS, NIH, Bethesda, MD USA
[8] Stanford Univ, Portola Valley, CA USA
[9] Vrije Univ Amsterdam, Amsterdam, Netherlands
关键词
RHEUMATOID ARTHRITIS; FLARE; WORSENING; DISEASE ACTIVITY; PATIENT PERSPECTIVE; OUTCOME MEASURES; PATIENT PERSPECTIVE; DOUBLE-BLIND; INFLIXIMAB; METHOTREXATE; THERAPY; ETANERCEPT; WITHDRAWAL; OUTCOMES; FATIGUE; DRUGS;
D O I
10.3899/jrheum.090369
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Traditional outcome measures in randomized controlled trials (RCT) include well-established response criteria its well as ACR EULAR responses using Disease Activity Score 44 (DAS44)/DAS28 to assess improvement; however, a measure to assess worsening of disease has yet to be developed. This special interest group (SIG) was established to develop an evidence-based, consensus-driven standard definition of "flare" in rheumatoid arthritis (RA). Methods. At OMERACT 8, the need fora standardized definition of RA flare was recognized; interested individuals developed a proposal to form a SIG. A literature review was performed to identify publications and abstracts with flare definitions applied in RA, JIA, and lupus RCT as well as concerning patient perspectives on disease worsening. A SIG was held at OMERACT 9 with breakout sessions for patients and investigators. Results. The RA flare SIG was attended by about 120 participants, including 11 patients. Patients and investigators held separate breakout sessions to discuss various aspects of disease worsening. The following consensus was obtained at OMERACT 9: it working definition of flare should indicate worsening of disease activity (88%), persistence, and duration its critical elements (77%), and consideration of change or increase in therapy (74%). Conclusion. A working definition of RA flare was developed based on these votes: flare is any worsening of disease activity that would, if persistent, in most cases lead to initiation or change of therapy; and a flare represents it cluster of symptoms of sufficient duration and intensity to require initiation, change, or increase in therapy. Using this working definition, evaluation of candidate domains will be conducted via Delphi exercise and further informed by patient focus groups. Validation of candidate definitions in appropriate RCT will be required. (First Release August 15 2009; J Rheumatol 2009:36:2335-41; doi: 10.3899/jrheum.090369)
引用
收藏
页码:2335 / 2341
页数:7
相关论文
共 39 条
[1]  
Aletaha D, 2006, Z RHEUMATOL, V65, P93, DOI 10.1007/s00393-006-0041-8
[2]  
Barrett JH, 2000, ARTHRITIS RHEUM, V43, P1010, DOI 10.1002/1529-0131(200005)43:5<1010::AID-ANR8>3.0.CO
[3]  
2-O
[4]  
Brunner HI, 2002, J RHEUMATOL, V29, P1058
[5]  
Caldwell JR, 1998, J RHEUMATOL, V25, P30
[6]  
Carr A, 2003, J RHEUMATOL, V30, P880
[7]   Measuring disease activity and functionality during pregnancy in patients with rheumatoid arthritis [J].
de Man, Yaeal A. ;
Hazes, Johanna M. W. ;
van de Geijn, Fleur E. ;
Krommenhoek, Catharina ;
Dolhain, Radboud J. E. M. .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2007, 57 (05) :716-722
[8]   Dose titration using the Disease Activity Score (DAS28) in rheumatoid arthritis patients treated with anti-TNF-α [J].
den Broeder, AA ;
Creemers, MCW ;
van Gestel, AM ;
van Riel, PLCM .
RHEUMATOLOGY, 2002, 41 (06) :638-642
[9]   Methotrexate dosage reduction in patients with rheumatoid arthritis beginning therapy with infliximab: the Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) trial [J].
Fleischmann, RM ;
Cohen, SB ;
Moreland, LW ;
Schiff, M ;
Mease, PJ ;
Smith, DB ;
Keenan, G ;
Kremer, JM .
CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (08) :1181-1190
[10]  
Fransen J, 2001, ARTHRITIS RHEUM-US, V44, P53, DOI 10.1002/1529-0131(200101)44:1<53::AID-ANR8>3.0.CO